Evidence map›Paper›PMID 41646948›Full record

ArticleESMO gastrointestinal oncology2024

Single-cell RNA sequencing of appendiceal adenocarcinoma reveals a low proportion of epithelial cells and a fibroblast enriched tumor microenvironment.

B B Gunes, N J Hornstein, M Wang, M Yousef, M M Fanaeian, A Yousef, S Chowdhury, M A Zeineddine, C Haymaker, B Helmink and 2 more

Abstract read
In one paragraph

Article in ESMO gastrointestinal oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

B B GunesDepartment of Medicine, University of California San Diego, La Jolla, USA.
N J HornsteinNorthwell, New Hyde Park, USA.
M WangDepartment of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
M YousefDepartment of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
M M FanaeianDepartment of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
A YousefDepartment of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
S ChowdhuryDepartment of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
M A ZeineddineDepartment of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
C HaymakerDepartment of Translational Molecular Pathology, University of Texas MD Anderson Cancer Center, Houston, USA.
B HelminkDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
K FournierDepartment of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.
J P ShenDepartment of Gastrointestinal Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Appendiceal adenocarcinoma (AA) is an understudied gastrointestinal malignancy. Treatment is guided by its proximal counterpart, colorectal cancer (CRC), despite recent studies demonstrating AA's unique mutational landscape and poor response to CRC chemotherapy. In this study, we describe AA on a single-cell level and uncover features highlighting the contrast between AA and CRC; we believe these findings will support AA as a unique disease entity and encourage further disease-specific focus. Materials and methods: Three patients with peritoneal metastases from AA and one from CRC profiled with 5' single-cell RNA sequencing. Results: Traditional k-means clustering analysis of >30 000 cells revealed three canonical compartments and 11 major cell types. AA samples were mostly comprised of stromal cells (56%), while healthy appendix samples had significantly more immune and epithelial cells. Strikingly, fibroblasts were the most abundant cell type in AA with cancer-associated fibroblasts from the mucinous AA tumors showing a distinct profile from goblet cell AA or CRC. Pseudobulk analysis comparing tumor cells from AA with normal appendiceal epithelial cells demonstrated up-regulation of a diverse range of oncogenic pathways including inflammatory, epithelial-mesenchymal transition, and angiogenesis. Conclusions: As the first application of single-cell technology to AA these data provide insight into the intratumor heterogeneity of AA and highlight the important contribution of the tumor microenvironment in this orphan disease. These results also reinforce multiple observations that AA is a unique disease entity from CRC and targeting the tumor microenvironment should be considered as a therapeutic strategy.

Indexed as

appendiceal adenocarcinomasingle-celltumor microenvironment

Identifiers

PMID41646948
PMCPMC12836597

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.